DiaMedica Therapeutics Inc. SEC filings DMAC
DiaMedica Therapeutics Inc. has 427 filings in SEC EDGAR's recent list, going back to May 16, 2007. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 1, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 1, 2026 | — |
| DEF 14A | Proxy statement | Apr 1, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 6, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Other events
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| S-8 | Employee stock plan registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 4 | Insider transaction | Nov 3, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Nov 3, 2025 | Aug 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 15, 2025 | — |
| 4 | Insider transaction | Sep 4, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 27, 2025 | — |
| EFFECT | Filing | Aug 22, 2025 | — |
| 424B2 | Prospectus | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2025 | — |
| 8-K |
Current report
Material agreement
|
Aug 12, 2025 | Aug 12, 2025 |
| S-3 | Shelf registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| EFFECT | Filing | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 6, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 6, 2025 | Aug 4, 2025 |
| UPLOAD | Letter from the SEC | Aug 5, 2025 | — |
| S-3 | Shelf registration | Aug 1, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 30, 2025 | — |
| 4 | Insider transaction | Jul 25, 2025 | Jul 23, 2025 |
| 4 | Insider transaction | Jul 25, 2025 | Jul 23, 2025 |
| 4 | Insider transaction | Jul 25, 2025 | Jul 23, 2025 |
| D | Filing | Jul 25, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2025 | Jul 17, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 7, 2025 |
| ARS | Annual report to shareholders | Mar 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| DEF 14A | Proxy statement | Mar 28, 2025 | May 15, 2025 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Feb 20, 2025 |
| 3 | Initial insider ownership | Feb 24, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| EFFECT | Filing | Jul 18, 2024 | — |
| 424B3 | Prospectus | Jul 18, 2024 | — |
| CORRESP | Letter to the SEC | Jul 16, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2024 | — |
| S-3 | Shelf registration | Jul 10, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jul 8, 2024 | — |
| D | Filing | Jul 2, 2024 | — |
| 144 | Notice of proposed sale | Jul 2, 2024 | — |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 26, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | Jun 1, 2024 |
| S-8 | Employee stock plan registration | May 24, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2024 | May 22, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2024 | Apr 5, 2024 |
| EFFECT | Filing | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 4, 2024 | — |
| ARS | Annual report to shareholders | Apr 4, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 4, 2024 | — |
| DEF 14A | Proxy statement | Apr 4, 2024 | May 22, 2024 |
| UPLOAD | Letter from the SEC | Mar 26, 2024 | — |
| S-3 | Shelf registration | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 22, 2024 |
| 3 | Initial insider ownership | Jan 23, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 2, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 2, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 2, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 2, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 2, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 16, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 5, 2023 | Sep 3, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 424B3 | Prospectus | Jul 10, 2023 | — |
| EFFECT | Filing | Jul 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 5, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 5, 2023 | — |
| S-3 | Shelf registration | Jun 30, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 27, 2023 | — |
| D | Filing | Jun 27, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 27, 2023 | — |
| 4 | Insider transaction | Jun 27, 2023 | Jun 23, 2023 |
| 3 | Initial insider ownership | Jun 27, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 23, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 23, 2023 | — |
| 3 | Initial insider ownership | Jun 23, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | Jun 2, 2023 | Jun 1, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 30, 2023 |
| 3 | Initial insider ownership | May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 18, 2023 | May 17, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| D | Filing | Apr 18, 2023 | — |
| 4 | Insider transaction | Apr 11, 2023 | Apr 10, 2023 |
| 3 | Initial insider ownership | Apr 11, 2023 | Apr 10, 2023 |
| ARS | Annual report to shareholders | Apr 4, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 4, 2023 | — |
| DEF 14A | Proxy statement | Apr 4, 2023 | May 17, 2023 |
| 10-K | Annual report | Mar 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 17, 2023 | May 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 10, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Mar 6, 2023 | Mar 1, 2023 |
| 3 | Initial insider ownership | Mar 6, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 6, 2023 | Mar 1, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 13, 2023 | — |
| 4 | Insider transaction | Jan 3, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 3, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 3, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 3, 2023 | Jan 3, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DMAC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Minneapolis, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1401040
- Former names
- DiaMedica Inc. (until Mar 11, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.